ROLE OF CARDIAC BIOMARKERS IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TREATED WITH CARDIAC MYOSIN INHIBITORS (CMI): A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Khan, Mohammad Ishrak [1 ]
Zahir, Raisa Subaita [1 ]
Martinez, Moises Abraham Vasquez [1 ]
Osorio, Paola A. Lecompte [1 ]
Aguilar-Gallardo, Jose S. [1 ]
Lorente-Ros, Marta [1 ]
Romeo, Francisco Jose [1 ]
机构：
[1] Icahn Sch Med Mt Sinai Morningside & West, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1323-123
引用
收藏
页码：530 / 530
页数：1
相关论文
共 50 条
  • [21] Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy Where Are We on the Hype Cycle?
    Ommen, Steve R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (02) : 109 - 110
  • [22] Aficamten Versus Placebo in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis
    Raja, Adarsh
    Rahman, Hafsah Alim Ur
    Ahmed, Muhammad
    Raja, Sandesh
    Arif, Fariha
    Asghar, Muhammad Sohaib
    AMERICAN JOURNAL OF THERAPEUTICS, 2025, 32 (02) : e184 - e186
  • [23] EFFICACY OF MAVACAMTEN IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Naveed, Hamza
    Aimen, Shafi Q.
    Javeed, Zainab
    Naeem, Minahil
    Ali, Shafaqat
    Basit, Jawad
    Alam, Mahboob
    Hamza, Mohammad
    Almas, Talal
    Sattar, Yasar
    Alraies, M. Chadi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 548 - 548
  • [24] Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis
    Norrish, Gabrielle
    Cantarutti, Nicoletta
    Pissaridou, Eleni
    Ridout, Deborah A.
    Limongelli, Giuseppe
    Elliott, Perry M.
    Kaski, Juan Pablo
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (11) : 1220 - 1230
  • [25] Factors associated with the risk of cardiac death in children with hypertrophic cardiomyopathy: a systematic review and meta-analysis
    Xia, Kun
    Sun, Dongming
    Wang, Ruigeng
    Zhang, Yong
    HEART & LUNG, 2022, 52 : 26 - 36
  • [26] Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging
    Vyas, Rahul
    Panchal, Viraj
    Jain, Shubhika
    Sondhi, Manush
    Singh, Mansunderbir
    Jaisingh, Keerthish
    Thotamgari, Sahith Reddy
    Thakre, Anuj
    Modi, Kalgi
    PLOS ONE, 2024, 19 (04):
  • [27] The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy: a scoping review
    Othman, Leen
    Koskina, Lida
    Huerta, Nicholas
    Rao, Shiavax J.
    HEART FAILURE REVIEWS, 2025, 30 (02) : 453 - 467
  • [28] The Efficacy of Cardiac Myosin Inhibitors versus Placebo in Patients With Symptomatic Hypertrophic Cardiomyopathy
    Yassen, Mohammad
    Khalid, Cameron Burmeister
    Changal, Khalid
    CIRCULATION, 2022, 146
  • [29] Role of biomarkers in early diagnosis and prognosis of cardiac amyloidosis: A systematic review and meta-analysis
    Albulushi, Arif
    Al Buraiki, Jehad
    Aly, Gamal
    Al-Wahshi, Yahya
    Jahangirifard, Alireza
    CURRENT PROBLEMS IN CARDIOLOGY, 2025, 50 (01)
  • [30] Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter
    Masri, Ahmad
    Olivotto, Iacopo
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (09):
12345